HDFC Pharma and Healthcare Fund

HDFC Mutual FundThematicPortfolio as of 31 July 2026

HDFC Pharma and Healthcare Fund holds 39 instruments (99.53% equity), led by Sun Pharmaceutical Industries Limited (9.66%), Divi's Laboratories Limited (9.14%) and Max Healthcare Institute Limited (4.82%), as of its 31 July 2026 SEBI-mandated monthly disclosure.

Holdings
39
Equity Allocation
99.53%
AMC
HDFC Mutual Fund
Category
Thematic

This page shows the complete disclosed portfolio of HDFC Pharma and Healthcare Fund, managed by HDFC Mutual Fund, based on its monthly portfolio disclosure dated 31 July 2026. The fund holds 39 instruments with an equity allocation of 99.53%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.

Portfolio Analysis

HDFC Pharma and Healthcare Fund's top 10 holdings account for 51.84% of its portfolio, in line with the Thematic category average of 50.4%. Healthcare is its largest sector exposure at 99.53% of net assets, spread across 1 sector in total. Since its 30 June 2026 disclosure, the fund added 3 new positions and exited 1 position, with Divi's Laboratories Limited seeing the largest move (+1.98pp to 9.14%).

Top 10 Equity Holdings

What Changed: June 2026 → July 2026

Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.

3 new entries1 exit4 increased10 reduced

Biggest Weight Increases

StockWeightChange
Divi's Laboratories Limited7.16% → 9.14%▲ +1.98
Dr. Reddy's Laboratories Limited1.04% → 1.92%▲ +0.88
Biocon Limited1.17% → 2.01%▲ +0.84
Neuland Laboratories Limited2.93% → 3.4%▲ +0.47

Biggest Weight Reductions

StockWeightChange
Acutaas Chemicals Limited4.58% → 3.58%▼ -1
Max Healthcare Institute Limited5.57% → 4.82%▼ -0.75
Lupin Limited5.26% → 4.67%▼ -0.59
Cipla Limited5.19% → 4.64%▼ -0.55
Fortis Healthcare Limited3.18% → 2.79%▼ -0.39
Krishna Institute of Medical Sciences Limited3.07% → 2.7%▼ -0.37
Aster DM Healthcare Limited5.05% → 4.7%▼ -0.35
Alkem Laboratories Limited4% → 3.67%▼ -0.33
IPCA Laboratories Limited3.53% → 3.22%▼ -0.31
Vijaya Diagnostic Centre Limited2.53% → 2.23%▼ -0.3

Top Holdings — Weight Trend

% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Feb – Jul 2026).

Feb: 9.81%, Mar: 10.2%, Apr: 8.05%, May: 9.2%, Jun: 9.96%, Jul: 9.66%
9.66%
Feb: 8.38%, Mar: 8.2%, Apr: 8.56%, May: 8.02%, Jun: 7.16%, Jul: 9.14%
9.14%
Feb: 6.36%, Mar: 5.96%, Apr: 5.93%, May: 5.26%, Jun: 5.57%, Jul: 4.82%
4.82%
Feb: 5.42%, Mar: 5.7%, Apr: 5.46%, May: 5.18%, Jun: 5.05%, Jul: 4.7%
4.7%
Feb: 6.44%, Mar: 6.65%, Apr: 6.07%, May: 5.45%, Jun: 5.26%, Jul: 4.67%
4.67%

Full Portfolio (39 holdings)

#HoldingSector% to NAV
1Sun Pharmaceutical Industries LimitedHealthcare9.66%
2Divi's Laboratories LimitedHealthcare9.14%
3Max Healthcare Institute LimitedHealthcare4.82%
4Aster DM Healthcare LimitedHealthcare4.7%
5Lupin LimitedHealthcare4.67%
6Cipla LimitedHealthcare4.64%
7Alkem Laboratories LimitedHealthcare3.67%
8Acutaas Chemicals LimitedHealthcare3.58%
9Anthem Biosciences LimitedHealthcare3.56%
10Neuland Laboratories LimitedHealthcare3.4%
11IPCA Laboratories LimitedHealthcare3.22%
12TREPS - Tri-party Repotreps3.09%
13Global Health LimitedHealthcare3.05%
14Fortis Healthcare LimitedHealthcare2.79%
15Krishna Institute of Medical Sciences LimitedHealthcare2.7%
16Glenmark Pharmaceuticals LimitedHealthcare2.59%
17JUPITER LIFE LINE HOSPITALSHealthcare2.45%
18Torrent Pharmaceuticals LimitedHealthcare2.28%
19Shilpa Medicare LimitedHealthcare2.25%
20Vijaya Diagnostic Centre LimitedHealthcare2.23%
21Metropolis Healthcare LimitedHealthcare2.14%
22Zydus Lifesciences LimitedHealthcare2.1%
23Biocon LimitedHealthcare2.01%
24Dr. Reddy's Laboratories LimitedHealthcare1.92%
25Wockhardt LimitedHealthcare1.89%
26Sai Life Sciences LimitedHealthcare1.62%
27Rubicon Research LimitedHealthcare1.61%
28Apollo Hospitals Enterprise LimitedHealthcare1.58%
29Thyrocare Technologies LimitedHealthcare1.42%
30Ajanta Pharma LimitedHealthcare1.28%
31Eris Lifesciences LimitedHealthcare1.25%
32CORONA Remedies LimitedHealthcare1.24%
33Gland Pharma LimitedHealthcare1.07%
34Jubilant Pharmova LimitedHealthcare1.01%
35Bajaj Healthcare LimitedHealthcare0.65%
36Novartis India LimitedHealthcare0.51%
37Laxmi Dental LimitedHealthcare0.47%
38Cohance Lifesciences LimitedHealthcare0.36%
39Net Current Assetsother-2.62%

Frequently Asked Questions

Yes. As of its 31 July 2026 disclosure, Sun Pharmaceutical Industries Limited is 9.66% of HDFC Pharma and Healthcare Fund's net assets — its number 1 holding.
Yes. As of its 31 July 2026 disclosure, Divi's Laboratories Limited is 9.14% of HDFC Pharma and Healthcare Fund's net assets — its number 2 holding.
Yes. As of its 31 July 2026 disclosure, Max Healthcare Institute Limited is 4.82% of HDFC Pharma and Healthcare Fund's net assets — its number 3 holding.
Yes. As of its 31 July 2026 disclosure, Aster DM Healthcare Limited is 4.7% of HDFC Pharma and Healthcare Fund's net assets — its number 4 holding.
Yes. As of its 31 July 2026 disclosure, Lupin Limited is 4.67% of HDFC Pharma and Healthcare Fund's net assets — its number 5 holding.

New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.

Source: HDFC Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 July 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.